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Personswithhigh-riskconditionssuchasasthmawereatargetgroupforH1N1vaccinerecommendations.Weconductedamailed
survey of a national sample of pulmonologists to understand their participation in the 2009-2010 H1N1 vaccine campaign. The
response rate was 59%. The majority of pulmonologists strongly recommended H1N1 vaccine for children (73%) and adults aged
25–64 years (51%). Only 60% of respondents administered H1N1 vaccine in their practice compared to 87% who oﬀered seasonal
inﬂuenza vaccine. Other than vaccine supply, respondents who provided H1N1 vaccine reported few logistical problems. Two-
thirds of respondents would be very likely to vaccinate during a future inﬂuenza pandemic; this rate was higher among those who
provided H1N1 vaccine and/or seasonal ﬂu vaccine. In total, the H1N1 vaccine-related experiences of pulmonologists seemed to
be positive. However, additional eﬀorts are needed to increase participation in future pandemic vaccination campaigns.
1.Introduction
In June 2009, the World Health Organization declared a
worldwidepandemic ofH1N1 inﬂuenza[1],and,inSeptem-
ber2009,anovelH1N1inﬂuenzavaccinewaslicensedforuse
in the United States [2]. As with seasonal inﬂuenza, persons
with asthma and other chronic respiratory conditions were
considered at high risk for H1N1 inﬂuenza and its complica-
tions [3].
Early reports indicated high rates of asthma among those
hospitalized and a younger age proﬁle among those hos-
pitalized than what is common for seasonal inﬂuenza [4–
6]. These data underscored the importance of vaccinating
high-risk children and nonelderly adults, as well as the need
for eﬀective strategies to reach these populations. In this
context, pulmonologists represented a provider group that
could vaccinate children and adults with asthma and other
high-risk respiratory conditions.
Unlike a typical inﬂuenza season, in which physicians
who oﬀer ﬂu vaccine purchase it in the private market, the
federal government purchased H1N1 vaccine and gave state
and local public health oﬃcials the responsibility for coordi-
nating the H1N1 vaccination campaign in their jurisdiction.
These responsibilities included enrollment of providers as
H1N1 vaccinators and distribution of H1N1 to enrolled
providers. The extent to which state and local public health
oﬃcials were able to involve subspecialists in the H1N1
vaccination campaign is unknown.
The goal of this study was to describe the experiences of
pulmonologists related to the 2009-2010 H1N1 vaccination
campaign to help inform future inﬂuenza vaccination cam-
paigns.
2. Methods
2.1. Sample. Through a contracted vendor, we drew a na-
tional random sample of 1,998 pulmonologists from the
American Medical Association (AMA) Physician Masterﬁle.
The AMA Physician Masterﬁle is a comprehensive database
of physicians licensed to practice in the United States,
and includes both AMA members and nonmembers. Our
sampling frame included all allopathic and osteopathic
physicians in oﬃce- or hospital-based, direct patient care,
with a self-reported primary specialty of pulmonary disease.
Excluded were physicians ≥70 years, in residency training or
employed at federal medical facilities.2 Pulmonary Medicine
2.2. Survey Design. The 4-page, 18-item survey instrument
incorporated factors known to be related to inﬂuenza vacci-
nation in general (e.g., strength of physician recommenda-
tion for vaccination [4–10], safety concerns about inﬂuenza
vaccine [4, 5, 8]), as well as practical and logistical issues
speciﬁc to the H1N1 vaccine campaign. Speciﬁc questions
included the following:
(i) typical recommendation regarding H1N1 vaccina-
tion for patients by age group (strongly recommended,
recommended, neutral, recommended against)a n d
whether recommended H1N1 vaccine for patients
during inpatient stays,
(ii) own and perceived patient level of concern with safe-
tyofH1N1vaccinerelativetothatofseasonalﬂuvac-
cine (much less, somewhat less, about the same, some-
what greater, much greater),
(iii) level of participation in the 2009-2010 H1N1 vaccine
campaign (agreed to provide H1N1 vaccine and re-
ceived vaccine, agreed to provide H1N1 vaccine but did
not receive vaccine, did not agree to provide H1N1 vac-
cine, and did not know about opportunities to provide
H1N1 vaccine),
(iv) among H1N1 vaccinators, experiences with adminis-
tering H1N1 vaccine, including month vaccine ﬁrst
available for patients, whether prioritized among
adult patients when supply was limited and, if so, to
which subgroups, and extent to which certain practi-
cal and logistical issues related to H1N1 vaccination
were problematic (not a problem, minor problem, ma-
jor problem),
(v) whether practice oﬀered seasonal ﬂu vaccine in 2009-
2010 and planned to oﬀer ﬂu vaccine for the 2010-
2011 inﬂuenza season,
(vi) likelihood of practice providing vaccine in the event
of a future inﬂuenza pandemic (very likely, somewhat
likely, neutral, somewhat unlikely, very unlikely), and
(vii) practice characteristics, including practice owner-
ship/aﬃliation and whether provide inpatient care.
The University of Michigan Medical School Institutional
Review Board approved this study.
2.3. Survey Administration. The initial survey mailing was
sent in June 2010 and included a $5 cash incentive. Two
additional mailings to nonrespondents occurred at approx-
imately 4-week intervals.
2.4. Data Analysis. We generated univariate frequencies for
each variable and then performed chi-square analyses to ex-
amine associations between key survey variables (e.g., H1N1
vaccine recommendation, H1N1 vaccinator status, likeli-
hood of participating in future inﬂuenza pandemic) and
practice and personal demographic characteristics. A two-
tailed α-level of 0.05 was the threshold for statistical signif-
icance. All analyses were conducted using SAS version 9.2
(SAS Institute, Cary, NC, USA).
Table 1: Respondent characteristics (N = 945).
%
Practice setting/aﬃliation
Private independent practice/network, IPA 82%
Hospital, Health system, Univ. medical center 17%
Public clinic, Community health center, other 1%
Patient mix
Pediatric and adult patients 63%
Adult patients only 37%
Provide any inpatient care
Yes 91%
No 9%
Oﬀered seasonal ﬂu vaccine during the 2009-2010
inﬂuenza season
Yes 87%
No/Unsure 13%
3. Results
3.1. Response Rate. Of the 1,998 pulmonologists in the mail-
ing sample, 107 were excluded because mailing materials
were returned as undeliverable. Completed surveys were re-
turned by 1,114 pulmonologists, yielding a response rate of
59%. Of these, 169 were ineligible because they do not pro-
vide any direct patient care in an outpatient setting. Thus,
the ﬁnal analytic sample included 945 respondents. Practice
characteristics of respondents are presented in Table 1.
3.2. H1N1 Vaccine Recommendation. Respondents’ strength
of recommendation for H1N1 vaccine varied by patient
age group (Table 2), with a strong recommendation most
common for pediatric patients. There were no consistent
or notable signiﬁcant diﬀerences in the strength of H1N1
vaccine recommendation by practice characteristics for any
of the three patient age groups.
3.3. H1N1 Vaccinator Status. As shown in Table 3, the ma-
jority (60%) of respondents received H1N1 vaccine to ad-
minister to patients (i.e., were H1N1 vaccinators), while a
small proportion agreed to participate but never received
vaccine. Nearly one-third of respondents did not agree to
participate or had not heard of opportunities to participate
in the H1N1 vaccine campaign. H1N1 vaccinator status was
associated with practice setting; all respondents in public
clinics and three-quarters of those based in hospitals were
H1N1 vaccinators. However, in private practice, the most
common practice setting, just over half of respondents were
H1N1 vaccinators. Pulmonologists whose practices oﬀered
seasonal ﬂu vaccine in 2009-2010 were much more likely to
be H1N1 vaccinators; less than 10% of those who did not
oﬀer seasonal ﬂu vaccine were H1N1 vaccinators.
3.4. Vaccine Safety Concerns. Eleven percent of respondents
reported that they had greater concerns about the safetyPulmonary Medicine 3
Table 2: Pulmonologists’ typical H1N1 vaccine recommendation by patient age group (N = 945)∗.
For patients Strongly recommended Recommended Neutral Recommended
against
≤18 Years 73% 18% 7% 2%
25–64 Years 51% 39% 9% 1%
≥65 Years 43% 33% 18% 6%
∗Results for each age group exclude respondents who do not provide care for patients of that age.
Table 3: H1N1 vaccinator status of pulmonologists and association with practice characteristics.
Variable
Agreed to
participate,
received vaccine
Agreed to
participate, did
not receive
vaccine
Did not agree to
participate
Did not know about
opportunities to
participate
Overall (N = 945) 60% 9% 20% 11%
Practice setting/aﬃliation∗†
Private independent practice/network (N = 760) 56% 10% 23% 11%
Hospital/health system (N = 165) 77% 5% 9% 9%
Public clinic/CHC/other (N = 6) 100% 0% 0% 0%
Oﬀered seasonal ﬂu vaccine for 2009-2010
inﬂuenza season∗†‡
Yes (N = 805) 68% 10% 14% 8%
No (N = 122) 9% 2% 59% 30%
∗P<. 001.
†CHC: community health center; N = 14 missing data.
‡Excludes “Unsure” category (N = 2); N = 16 missing data.
of H1N1 vaccine than seasonal inﬂuenza vaccine, 59% had
“about the same” level of concern, and 30% had less concern
about the safety of H1N1 vaccine. Respondents who had a
greater concern about H1N1 vaccine safety were less likely to
stronglyrecommendH1N1vaccinethanthosewhoselevelof
concern was similar or lower; this ﬁnding was consistent for
all three patient age groups (P = .018 for pediatric patients,
and P<. 001 for both adults 25–64 years and seniors).
In addition, respondents who reported safety concerns were
less likely to be H1N1 vaccinators compared to those with a
similarorlowerlevelofconcern(36%versus63%,P<. 001).
With regard to patients’ safety concerns, 52% of respon-
dents perceived that patients were more concerned with the
safety of H1N1 vaccine relative to seasonal inﬂuenza vaccine.
Another 33% felt that their patients’ level of concern was
“about the same,” while 15% perceived patient concerns to
be less for H1N1 vaccine than seasonal ﬂu vaccine. Perceived
patient concern was not associated with physicians’ self-
reported strength of recommendation for H1N1 vaccine or
H1N1 vaccinator status.
3.5. Experiences of H1N1 Vaccinators. Among H1N1 vac-
cinators, the ﬁrst month in which respondents reported
having vaccine available for patients was 20% October, 34%
November, 20% December, and 7% January or later; 19%
were unsure of the timing of vaccine availability. Most H1N1
vaccinators oﬀered vaccine at scheduled visits (74%) or on
a walk-in basis (62%), with just under half (45%) oﬀering
both options.
Based on the practical and logistical issues with H1N1
vaccination listed in Table 4, vaccine supply was the main
challenge for H1N1 vaccinators. Across all of the issues listed
in Table 4, 39% of respondents rated one of these issues as
a major problem, 13% said two of these issues were major
problems, 7% rated three or more as major problems, and
41% of respondents reported no major problems.
3.6. Future Participation in Inﬂuenza Vaccination. Most re-
spondents (86%) reported that their practice planned to
oﬀer seasonal ﬂu vaccine for the 2010-2011 inﬂuenza season,
whichwassimilartotheproportionoﬀeringseasonalﬂuvac-
cine for the 2009-2010 season (87%). A smaller proportion
(65%) said their practice would be “very likely” to provide
vaccine in the event of a future inﬂuenza pandemic, with
another 13% indicating their practice would be “somewhat
likely”toparticipate.Anadditional8%wereneutral,5%said
“somewhat unlikely,” and 9% said “very unlikely.”
Being “very likely” to provide vaccine in a future inﬂu-
enza pandemic was more common among those who oﬀered
versus did not oﬀer seasonal ﬂu vaccine during the 2009-
2010 inﬂuenza season (72% versus 19%, P<. 001) and
amongH1N1vaccinatorsversusnonvaccinators(84%versus
34%, P<. 001). Among H1N1 vaccinators, being “very
likely” to participate in a future inﬂuenza pandemic was less
commonamongthosewhoratedtwoormoreoftheissuesin
Table 4 as major problems compared to those who said none
or one of the issues was a major problem (64% versus 86%,
P = .002).4 Pulmonary Medicine
Table 4: Extent of problems experienced by pulmonologists providing H1N1 vaccine (N = 564).
Not a problem Minor problem Major problem
Inadequate or inconsistent H1N1 vaccine supply 18% 37% 45%
Lack of patient acceptance (demand) for H1N1 vaccine 50% 42% 8%
Elderly patients frustrated with lower priority for vaccine 39% 48% 13%
Staﬀ unfamiliar with diﬀerent H1N1 vaccine products 78% 21% 1%
Storage/handling of H1N1 vaccine 83% 15% 2%
Reimbursement/billing for vaccine administration 70% 24% 6%
H1N1 reporting requirements 51% 39% 10%
Return/disposal of unused H1N1 vaccine 66% 27% 7%
4. Discussion
Summary data on hospitalizations and deaths resulting from
the 2009-2010 H1N1 inﬂuenza [11, 12] conﬁrmed initial
reports [4–6] that persons with asthma and other chronic
conditions were at higher risk for morbidity and mortality
and, therefore, an important target for H1N1 vaccination.
One strategy for reaching these populations was to include
subspecialists, such as pulmonologists, in the 2009-2010
H1N1 vaccination campaign.
Assessing physician participation in public health cam-
paigns is a critical aspect of understanding the extent to
which a shared public health-medical delivery system is
feasible for future pandemic-type events. A positive ﬁnding
from this study is that a majority of pulmonologists surveyed
participated in the 2009-2010 H1N1 vaccination campaign
as H1N1 vaccinators. The importance of including physi-
cians that can reach high-risk populations is supported by
recent data showing that persons at high risk are more likely
than those not at high risk to receive ﬂu vaccine at a doctor’s
oﬃce versus other locations [13].
Of concern, however, is that participation was lowest in
private pulmonology practices (respondents’ most common
practice setting) relative to hospital-based and public sector
practices. This highlights a challenge for state and local pub-
lic health oﬃcials in recruiting physicians to assist with pan-
demic vaccination campaigns. While these oﬃcials may be
able to build upon existing relationships with hospitals to
reach hospital-based providers, recruiting private practices is
likelymoretimeandresourceintensive,aseachpracticemust
be contacted individually. In addition, from the physicians’
perspective, smaller independent practices may be less likely
to want, or to have the capacity, to take on an additional vac-
cine.
Participation in the H1N1 vaccination campaign among
those who did not provide seasonal ﬂu vaccine in 2009-
2010 was much lower, and approximately one-third of these
respondents said they did not know about opportunities
to provide H1N1 vaccine, suggesting that it is particularly
diﬃcult to reach those who are not already “plugged in” to
the immunization delivery system. For this reason, pub-
lic health oﬃcials may ﬁnd it easier to recruit primary
care physicians for pandemic vaccination eﬀorts. However,
including subspecialists is important for reaching persons at
high risk. For example, although the majority of ambulatory
care visits for asthma and other chronic pulmonary condi-
tions are to primary care oﬃces, about one-third of these
visits are to medical subspecialty oﬃces [14]. Focusing solely
on primary care physicians would likely miss a subset of this
high-risk population.
Overall, a high proportion of pulmonologists recom-
mended H1N1 vaccine to their patients. Given that virtually
all of their patients less than 65 years of age would be
classiﬁed as high risk for H1N1 vaccine, it is unclear why the
proportion who “strongly recommended” vaccination was
much higher for patients 18 years and younger compared to
those aged 25–64 years. Because all children were an initial
target group for vaccination, not just the high-risk subgroup,
it may have been easier for physicians to emphasize vacci-
nation for this patient group. It is also possible that state or
localpublichealthormedicalcommunitymessagesmayhave
focused more attention on vaccinating children.
The proportion of pulmonologists who strongly recom-
mended H1N1 vaccine to adults aged 25–64 years was only
slightly higher than the proportion for adults aged 65 years
and older, despite the fact that the latter population was
not an initial target group for H1N1 vaccination. Expansion
beyond the initial target groups was recommended ﬁrst for
all adults aged 25–64 years and then, once demand for the
younger age groups was met, to those aged 65 years and over,
regardless of high-risk status [3]. It is possible that some
pulmonologists may have been unaware of the diﬀerential
recommendations for these populations, or that, by the time
vaccine was available in their practice setting, the target
group recommendations were no longer needed. It is also
possible that some pulmonologists disagreed with the rec-
ommendations, feeling that the presence of a high-risk pul-
monary condition preempted an age-based determination.
While the proportion of respondents having greater con-
cerns with the safety of H1N1 vaccine relative to seasonal
ﬂu vaccine was not large, those with greater concerns were
much less likely to strongly recommend H1N1 vaccine to
their patients and participate as H1N1 vaccinators. Future
campaigns should stress the importance of proactive and
widespread messages directed toward physicians regarding
vaccine safety.
By far the biggest challenge faced by H1N1 vaccinators
was the limited supply of vaccine. Although the majority of
respondents reported receiving vaccine by November, the
peak of disease, and likely of patient demand, occurred priorPulmonary Medicine 5
to widespread vaccine availability. This was a signiﬁcant and
broadly experienced challenge during the H1N1 vaccination
campaign [15] and also varied by state or local area. Other-
wise, few issues caused major problems for pulmonologists
providing H1N1 vaccine, and many reported experiencing
no major problems.
A majority of respondents felt their practice would be
“very likely” to provide vaccine in the event of a future inﬂu-
enza pandemic. Respondents who were H1N1 vaccinators
weremuchmorelikelytoexpresswillingnesstoparticipatein
the event of a future pandemic, as were those who provided
seasonal ﬂu vaccine in 2009-2010. Although the proportion
very likely to participate in a future inﬂuenza pandemic was
similar to the proportion that was H1N1 vaccinators, it is
markedly lower than the proportion providing seasonal ﬂu
vaccine, implying that outpatient pulmonologists do not
see themselves as essential to a pandemic response. Public
health and emergency preparedness oﬃcials may want to
work toward including subspecialty physicians, such as
pulmonologists, in short-term planning eﬀorts, in order to
accomplish longer-term objective of creating a broad base of
vaccinators for pandemic response. In addition, pulmonolo-
gists interested in vaccinating can be proactive in reaching
out to public health oﬃcials during a pandemic. Strategies
for encouraging pulmonologists’ participation in pandemic
vaccination should continue to be explored.
5. Limitations
As with any survey study, there are limitations of response
bias; however, the response rates obtained in this study were
quite favorable, compared to other physician surveys. Also,
given the sample size, we were unable to make statistically
viable state-by-state comparisons of the results. The major
limitation with this study is that our pulmonologist sample
is not generalizable to the full universe of pulmonologists.
We included physicians in our sample whose self-reported
primary specialty is pulmonary disease but did not include
the other potentially applicable primary specialty of pul-
monary critical care medicine. To be eligible for our study,
respondents needed to provide patient care in an outpatient
setting, and we felt that a high proportion of physicians
reporting pulmonary critical care medicine as their primary
specialty would not provide outpatient care. As it turns out,
respondents reporting a specialty of pulmonary disease are
skewed to older, male physicians; the sample included no
one under the age of 40 years. In exploring this issue further,
we found that recent research has shown that pulmonology
alone is not a popular choice among internal medicine
residents and that pulmonology with critical care is more
likely to be chosen than either pulmonology or critical care
alone [16]. We went back to the contracted vendor and
requested year of birth frequency counts from the AMA
Masterﬁle, using our initial sample speciﬁcations, for all
physicians reporting a primary specialty of either pulmonary
critical care medicine or pulmonary disease. Comparing year
of birth data across the two groups conﬁrmed that younger
physicians are reporting pulmonary critical care medicine
as their primary specialty to the exclusion of pulmonary
disease. Given this limitation, our results likely under-re-
port the experiences of hospital-based pulmonologists and
likely provide a conservative estimate of pulmonologists’
participation in the H1N1 vaccination campaign.
6. Conclusion
Federal, state, and local public health oﬃcials should be en-
couraged to include pulmonologists in future pandemic
inﬂuenza planning and vaccination eﬀorts as an eﬀective
strategy for reaching persons with asthma and other chronic
respiratoryconditions.Theexperiencesofasubsetofpulmo-
nologists in the H1N1 vaccine campaign were generally pos-
itive, with the majority recommending the vaccine to their
patients and serving as H1N1 vaccinators. However, there
is much room for improvement in terms of participation
levels, and the challenges related to participation by private
practices must be further explored.
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